The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

29 Oct 2021 14:28

RNS Number : 7752Q
Quixant PLC
29 October 2021
 

29 October 2021

Quixant plc

("Quixant" or the "Company")

Grant of Options

 

Quixant (AIM:QXT), a leading provider of innovative, highly engineered technology products principally for the global gaming and broadcast industries, announces that on 25 October 2021 the Board granted a total of 125,000 options ("Options") over ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares") to Johan Olivier, Chief Financial Officer of the Company, as follows:

 

Number of Shares

Exercise price

100,000

190p

25,000

0.1p

 

The Options are exercisable from the date of the release of the Company's accounts for the year ending 31 December 2023. The Options are exercisable subject to the growth of the diluted earnings per Ordinary Share (as set out in each of the audited accounts for the years ending 31 December 2021, 2022 and 2023) being equal to or greater than 10 per cent in each financial year.

 

Following the Grant, there are a total of 1,314,790 Options outstanding, representing approximately 2% of the current issued share capital of the Company.

Further detail is set out in the PDMR disclosure table below.

 

Quixant plc

Jon Jayal, Chief Executive Officer

Johan Olivier, Chief Financial Officer

 

Tel: +44 (0)1223 892 696

Nominated Adviser and Broker:

finnCap Ltd

Matt Goode / Simon Hicks (Corporate Finance)

Alice Lane (ECM)

 

Tel: +44 (0) 20 7220 0500

Joint Broker:

Canaccord Genuity Limited

Simon Bridges / Andrew Potts

 

Tel: +44 (0) 20 7523 8000

Financial PR:

Alma PR

John Coles / Hilary Buchanan / Kieran Breheny

Tel: +44 (0)20 3405 0205

 

About Quixant

Quixant, founded in 2005, designs and manufactures highly optimised computing solutions and monitors principally for the global gaming and broadcast industries. The Company is headquartered in Cambridge in the UK, with offices throughout Europe, North America and Asia. Quixant has its own manufacturing and engineering operation based in Taiwan and software engineering and customer support teams based in Italy and Slovenia. All the specialised products software and manufacturing are produced in-house and Quixant owns all its own IP some of which is protected by patents and design rights.

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced sales team, Quixant has a robust platform to build its business into wider industrial markets. In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Johan Olivier

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Quixant plc

b)

LEI:

2138003VERSWQP561X71

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Options over Ordinary shares of 0.1p

 

GB00B99PCP71

b)

Nature of the transaction:

Purchase of ordinary shares of 0.1p

c)

Price(s) and volume(s):

Price(s)

Volume(s)

190.0p

100,000

0.1p

25,000

d)

Aggregated information:

· Aggregated volume:

· Price:

See 4 (c)

e)

Date of the transaction:

25 October 2021

f)

Place of the transaction:

Off market transaction

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZZMZGFLNGMZM
Date   Source Headline
15th Mar 20177:00 amRNSSenior Management Update
2nd Mar 20177:00 amRNSNotice of Results
27th Jan 20177:00 amRNSTrading Update and Notice of Results
22nd Dec 201611:16 amRNSHolding(s) in Company
20th Dec 20165:06 pmRNSResult of Placing
20th Dec 20163:04 pmRNSProposed Secondary Placing
24th Nov 20162:05 pmRNSSecond Price Monitoring Extn
24th Nov 20162:00 pmRNSPrice Monitoring Extension
24th Nov 201611:05 amRNSSecond Price Monitoring Extn
24th Nov 201611:00 amRNSPrice Monitoring Extension
24th Nov 20167:00 amRNSTrading Update
21st Nov 20163:26 pmRNSAppointment of Company Secretary
27th Oct 20166:27 pmRNSHolding(s) in Company
19th Oct 20164:54 pmRNSIssue of Equity
6th Oct 20161:38 pmRNSIssue of Equity
21st Sep 20165:03 pmRNSHolding(s) in Company
14th Sep 20167:00 amRNSHalf-year Report
11th Aug 20167:00 amRNSNotice of Interim Results
27th Jul 20167:00 amRNSTrading Update and Notice of Results
20th Jun 20167:00 amRNSBoard Appointment
15th Jun 20164:57 pmRNSDirector Dealing
9th Jun 20164:32 pmRNSIssue of Equity
7th Jun 20167:00 amRNSHolding(s) in Company
23rd May 20168:17 amRNSSigning of Multi-Year Contract
26th Apr 201611:46 amRNSResult of AGM
6th Apr 20166:18 pmRNSDirector Dealing
6th Apr 20167:00 amRNSHolding(s) in Company
4th Apr 201610:53 amRNSCompleted Secondary Placing
23rd Mar 20167:00 amRNSFinal Results
19th Feb 20167:00 amRNSNotice of Results
15th Feb 201611:29 amRNSHolding(s) in Company
21st Jan 20167:00 amRNSTrading Update
13th Nov 20159:32 amRNSHolding(s) in Company
11th Nov 20157:00 amRNSCompletion of Acquisition
10th Nov 20153:40 pmRNSScheme of Arrangement Becomes Effective
6th Nov 201511:33 amRNSScheme of Arrangement Sanctioned By Court
3rd Nov 20155:13 pmRNSResults of Court Meeting and General Meeting
9th Oct 20157:00 amRNSPosting of Scheme Document
2nd Oct 201510:33 amRNSHolding in Company
1st Oct 20153:36 pmRNSForm 8 (OPD) Densitron Technologies plc
30th Sep 20153:33 pmRNSForm 8 (OPD) Quixant plc
25th Sep 20157:00 amRNSRule 2.7 Announcement
16th Sep 20157:00 amRNSHalf Yearly Report
3rd Aug 20159:48 amRNSHolding(s) in Company
22nd Jul 20157:00 amRNSTrading Update and Notice of Results
21st Apr 20157:00 amRNSQueen's Award for Enterprise
16th Apr 201511:01 amRNSResult of AGM
24th Mar 20151:41 pmRNSPosting of Annual Report and Accounts
24th Mar 20157:00 amRNSFinal Results
4th Mar 20157:00 amRNSNotice of Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.